These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7587986)

  • 1. Finasteride and benign prostatic hyperplasia.
    Drug Ther Bull; 1995 Mar; 33(3):19-21. PubMed ID: 7587986
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug treatment for benign prostatic hyperplasia. Several trials have shown benefit of finasteride.
    Collins GN
    BMJ; 1997 Aug; 315(7104):371. PubMed ID: 9270474
    [No Abstract]   [Full Text] [Related]  

  • 3. Finasteride for BPH.
    Johnson KH; Casey CM
    J Fam Pract; 1998 Jun; 46(6):455-6. PubMed ID: 9638104
    [No Abstract]   [Full Text] [Related]  

  • 4. Benign prostatic hyperplasia: caveat for finasteride should be discussed before prescribing.
    Ammar H; Malani AK; Gupta C
    BMJ; 2006 Sep; 333(7569):654; author reply 654. PubMed ID: 16990336
    [No Abstract]   [Full Text] [Related]  

  • 5. Meta-analysis of randomized clinical trials of finasteride.
    Roehrborn CG
    Urology; 1998 Apr; 51(4A Suppl):46-9. PubMed ID: 9586596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benign prostatic hyperplasia. Finasteride controls progression of BPH].
    MMW Fortschr Med; 2000 Jun; 142(25):62-3. PubMed ID: 10920676
    [No Abstract]   [Full Text] [Related]  

  • 7. Finasteride for the treatment and control of benign prostatic hyperplasia: summary of phase III controlled studies. The Finasteride Study Group.
    Grino P; Stoner E
    Eur Urol; 1994; 25 Suppl 1():24-8. PubMed ID: 7507052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finasteride in benign prostatic hyperplasia.
    Wysowski DK; Farinas E
    N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15044649
    [No Abstract]   [Full Text] [Related]  

  • 9. 5 alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia.
    Stoner E
    Recent Prog Horm Res; 1994; 49():285-92. PubMed ID: 7511828
    [No Abstract]   [Full Text] [Related]  

  • 10. [Finasteride in the treatment of benign prostatic hypertrophy].
    Ekman P
    J Urol (Paris); 1993; 99(6):299-302. PubMed ID: 7516372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.
    Corona G; Tirabassi G; Santi D; Maseroli E; Gacci M; Dicuio M; Sforza A; Mannucci E; Maggi M
    Andrology; 2017 Jul; 5(4):671-678. PubMed ID: 28453908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of finasteride on hematuria associated with benign prostatic hyperplasia: a meta-analysis].
    Jiang Y; Long YF
    Zhonghua Nan Ke Xue; 2010 Aug; 16(8):726-9. PubMed ID: 21090349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign prostatic hyperplasia.
    Geller J
    Curr Ther Endocrinol Metab; 1994; 5():550-6. PubMed ID: 7535664
    [No Abstract]   [Full Text] [Related]  

  • 14. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H; Williford WO; Barry MJ; Brawer MK; Dixon CM; Gormley G; Haakenson C; Machi M; Narayan P; Padley RJ
    N Engl J Med; 1996 Aug; 335(8):533-9. PubMed ID: 8684407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign prostatic hypertrophy: update on drug therapy.
    Tejani A; Musini V; Perry TL; Mintzes B; Wright JM
    Can Fam Physician; 2006 Sep; 52(9):1075-6, 1077-8. PubMed ID: 17279217
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing benign prostatic hyperplasia.
    Barkin J
    CMAJ; 1997 Apr; 156(7):978-9. PubMed ID: 9099163
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride.
    Zlotta AR; Teillac P; Raynaud JP; Schulman CC
    Eur Urol; 2005 Aug; 48(2):269-76. PubMed ID: 15939527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finasteride: new indication. Benign prostatic hypertrophy: sexual disorders.
    Prescrire Int; 2007 Aug; 16(90):147. PubMed ID: 17724838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia.
    Wessells H; Roy J; Bannow J; Grayhack J; Matsumoto AM; Tenover L; Herlihy R; Fitch W; Labasky R; Auerbach S; Parra R; Rajfer J; Culbertson J; Lee M; Bach MA; Waldstreicher J;
    Urology; 2003 Mar; 61(3):579-84. PubMed ID: 12639651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finasteride may prevent prostate cancer.
    Thompson CA
    Am J Health Syst Pharm; 2003 Aug; 60(15):1511, 1515. PubMed ID: 12951749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.